As of 2025-05-23, the Fair Value of Sarepta Therapeutics Inc (SRPT) is -63.20 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 38.79 USD, the upside of Sarepta Therapeutics Inc is -262.92%.
With the market price of 38.79 USD and our fair value calculation, Sarepta Therapeutics Inc (SRPT) is not a good investment. Investing in SRPT stocks now will result in a potential loss of 262.92%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -554.10 | -418.80 | -703.50 | -535.98 | 235.24 | -395.43 |
| YoY growth | 22.51% | 24.42% | -67.98% | 23.81% | 143.89% | 29.33% |
| Market Cap (mil) | 3,811.51 |
| P/E | |
| Forward P/E | 11.59x |
| EPS | -2.53 |
| Avg earnings growth rate | 29.33% |
| TTM earnings | -248.39 |